Download PDF
J Neurol Surg A Cent Eur Neurosurg 2021; 82(03): 204-210
DOI: 10.1055/s-0040-1720982
Original Article

Health Economic Aspects of Aneurysmal Subarachnoid Hemorrhage: Factors Determining First Year In-Hospital Treatment Expenses

Sami Ridwan
1   Department of Neurosurgery, University Hospital Bonn, Bonn, Germany
2   Department of Neurosurgery, Paracelsus Hospital Osnabruck, Osnabruck, Germany
,
Horst Urbach
3   Department of Radiology, University Hospital Bonn, Bonn, Germany
4   Department of Neuroradiology, University Medical Center Freiburg, Freiburg, Germany
,
Susanne Greschus
3   Department of Radiology, University Hospital Bonn, Bonn, Germany
5   Department of Radiology, Evangelische Kliniken Johanniter- und Waldkrankenhaus Bonn gGmbH, Bonn, Germany
,
Johanna Von Hagen
1   Department of Neurosurgery, University Hospital Bonn, Bonn, Germany
,
Jonas Esche
6   Department of Nutrition and Food Science, Universität Bonn, Bonn, Germany
,
Azize Boström
1   Department of Neurosurgery, University Hospital Bonn, Bonn, Germany
7   Department of Neurosurgery, MediClin Robert Janker Hospital, Bonn, Germany
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Abstract

Background Spontaneous aneurysmal subarachnoid hemorrhage (SAH) is a common neurosurgical emergency with a high case fatality rate. The clinical course of SAH generates high health economic expenses. Here we highlight possible cost-driving factors for in-hospital care expenses for the first year. Furthermore, results are compared with ischemic stroke treatment.

Methods One hundred and one patients with aneurysmal SAH treated in our hospital from 2007 through 2009 were included. The Hunt and Hess (HH) scale, World Federation of Neurosurgical Societies (WFNS) scale, Fisher Scale, and further outcome-relevant data were recorded. Expenses were calculated using the German fixed case rate classification system consisting of Diagnosis-Related Groups (DRG) and the Operation and Procedure catalogue (OPS). Overall acute length of stay (LOS) and LOS on the intensive care unit (ICU) were separately evaluated. Expenses were compared with formerly published first-year costs of ischemic stroke.

Results Fifty-four percent of the patients (median age 52 years, 69% females) received coiling and 46% clipping. Acute in-hospital treatment accounted for 82% of total in-hospital expenses, while consequential in-hospital treatment accounted only for 18%. Altogether, the total first-year in-hospital expenses for all patients were as high as €2,650,002, resulting in average SAH in-hospital treatment expenses of €26,238 per patient for the first year. Poor clinical condition on admission and longer stay in ICU are the main cost-driving factors. The impact of the aneurysm treatment method is debatable. Only a poor HH grade and longer ICU stay are independent cost-driving factors. SAH treatment expenses are far higher than treatment costs for ischemic stroke in the literature (€6,731 for first-year inpatient and €3,287 for outpatient treatment).

Conclusions Clinical condition and LOS determine in-hospital expenses after SAH. Aneurysmal SAH prevalently results in a relevant economic impact on the health system exceeding formerly published treatment expenses for ischemic stroke.

Keywords

cost driving - treatment - subarachnoid hemorrhage - stroke - aneurysm


Publication History

Received: 20 December 2019

Accepted: 14 April 2020

Article published online:
24 January 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Kolominsky-Rabas PL, Heuschmann PU, Marschall D. et al. Lifetime cost of ischemic stroke in Germany: results and national projections from a population-based stroke registry: the Erlangen Stroke Project. Stroke 2006; 37 (05) 1179-1183
    CrossrefPubMedGoogle Scholar
  • 2 Dodel R, Winter Y, Ringel F. et al. Cost of illness in subarachnoid hemorrhage: a German longitudinal study. Stroke 2010; 41 (12) 2918-2923
    CrossrefPubMedGoogle Scholar
  • 3 Komotar RJ, Schmidt JM, Starke RM. et al. Resuscitation and critical care of poor-grade subarachnoid hemorrhage. Neurosurgery 2009; 64 (03) 397-410 , discussion 410–411
    CrossrefPubMedGoogle Scholar
  • 4 Etminan N, Chang HS, Hackenberg K, de Rooij NK, Vergouwen MDI, Rinkel GJE, Algra A. Worldwide incidence of aneurysmal subarachnoid hemorrhage according to region, time period, blood pressure, and smoking prevalence in the population: a systematic review and meta-analysis. JAMA Neurol 2019; 76 (05) 588-597
    CrossrefPubMedGoogle Scholar
  • 5 Gesundheitsberichterstattung. Epidemiology of cerebrovascular diseases in Germany. Accessed February 15, 2015 at: www.gbe-bund.de
    Google Scholar
  • 6 Bairstow P, Dodgson A, Linto J, Khangure M. Comparison of cost and outcome of endovascular and neurosurgical procedures in the treatment of ruptured intracranial aneurysms. Australas Radiol 2002; 46 (03) 249-251
    CrossrefPubMedGoogle Scholar
  • 7 Hoh BL, Chi Y-Y, Lawson MF, Mocco J, Barker II FG. Length of stay and total hospital charges of clipping versus coiling for ruptured and unruptured adult cerebral aneurysms in the Nationwide Inpatient Sample database 2002 to 2006. Stroke 2010; 41 (02) 337-342
    CrossrefPubMedGoogle Scholar
  • 8 Hoh BL, Chi Y-Y, Dermott MA, Lipori PJ, Lewis SB. The effect of coiling versus clipping of ruptured and unruptured cerebral aneurysms on length of stay, hospital cost, hospital reimbursement, and surgeon reimbursement at the university of Florida. Neurosurgery 2009; 64 (04) 614-619 , discussion 619–621
    CrossrefPubMedGoogle Scholar
  • 9 Winter Y, Wolfram C, Schaeg M. et al. Evaluation of costs and outcome in cardioembolic stroke or TIA. J Neurol 2009; 256 (06) 954-963
    CrossrefPubMedGoogle Scholar
  • 10 Qureshi AI, Suri MFK, Nasar A. et al. Changes in cost and outcome among US patients with stroke hospitalized in 1990 to 1991 and those hospitalized in 2000 to 2001. Stroke 2007; 38 (07) 2180-2184
    CrossrefPubMedGoogle Scholar
  • 11 Evers SMAA, Struijs JN, Ament AJHA, van Genugten MLL, Jager JHC, van den Bos GAM. International comparison of stroke cost studies. Stroke 2004; 35 (05) 1209-1215
    CrossrefPubMedGoogle Scholar
  • 12 Back T, Schaeg M, Back C. et al. Costs of stroke unit care in Germany. Resource use and reimbursements by German diagnosis related groups. Nervenarzt 2004; 75 (10) 991-999
    CrossrefPubMedGoogle Scholar
  • 13 Winter Y, Wolfram C, Schöffski O, Dodel RC, Back T. Long-term disease-related costs 4 years after stroke or TIA in Germany. Nervenarzt 2008; 79 (08) 918-920 , 922–924, 926
    CrossrefPubMedGoogle Scholar
  • 14 Saka O, McGuire A, Wolfe C. Cost of stroke in the United Kingdom. Age Ageing 2009; 38 (01) 27-32
    CrossrefPubMedGoogle Scholar
  • 15 Epifanov Y, Dodel R, Haacke C. et al. Costs of acute stroke care on regular neurological wards: a comparison with stroke unit setting. Health Policy 2007; 81 (2–3): 339-349
    CrossrefPubMedGoogle Scholar
  • 16 Demaerschalk BM, Hwang H-M, Leung G. US cost burden of ischemic stroke: a systematic literature review. Am J Manag Care 2010; 16 (07) 525-533
    PubMedGoogle Scholar
  • 17 Venketasubramanian N, Yin A. Hospital costs for stroke care in Singapore. Cerebrovasc Dis 2000; 10 (04) 320-326
    CrossrefPubMedGoogle Scholar
  • 18 Roos YBWEM, Dijkgraaf MGW, Albrecht KW. et al. Direct costs of modern treatment of aneurysmal subarachnoid hemorrhage in the first year after diagnosis. Stroke 2002; 33 (06) 1595-1599
    CrossrefPubMedGoogle Scholar
  • 19 Rivero-Arias O, Wolstenholme J, Gray A. et al. The costs and prognostic characteristics of ischaemic neurological deficit due to subarachnoid haemorrhage in the United Kingdom. Evidence from the MRC International Subarachnoid Aneurysm Trial. J Neurol 2009; 256 (03) 364-373
    CrossrefPubMedGoogle Scholar
  • 20 Javadpour M, Jain H, Wallace MC, Willinsky RA, ter Brugge KG, Tymianski M. Analysis of cost related to clinical and angiographic outcomes of aneurysm patients enrolled in the international subarachnoid aneurysm trial in a North American setting. Neurosurgery 2005; 56 (05) 886-894 , discussion 886–894
    PubMedGoogle Scholar
  • 21 Wolstenholme J, Rivero-Arias O, Gray A. International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group. et al. Treatment pathways, resource use, and costs of endovascular coiling versus surgical clipping after aSAH. Stroke 2008; 39 (01) 111-119
    CrossrefPubMedGoogle Scholar
  • 22 Ridwan S, Urbach H, Greschus S, von Hagen J, Esche J, Boström A. Health care costs of spontaneous aneurysmal subarachnoid hemorrhage for rehabilitation, home care, and in-hospital treatment for the first year. World Neurosurg 2017; 97: 495-500
    CrossrefPubMedGoogle Scholar
  • 23 Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 1968; 28 (01) 14-20
    CrossrefPubMedGoogle Scholar
  • 24 Teasdale GM, Drake CG, Hunt W. et al. A universal subarachnoid hemorrhage scale: report of a committee of the World Federation of Neurosurgical Societies. J Neurol Neurosurg Psychiatry 1988; 51 (11) 1457
    CrossrefPubMedGoogle Scholar
  • 25 Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980; 6 (01) 1-9
    CrossrefPubMedGoogle Scholar
  • 26 Burn JP. Reliability of the modified Rankin Scale. Stroke 1992; 23 (03) 438
    CrossrefPubMedGoogle Scholar
  • 27 Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet 1975; 1 (7905): 480-484
    CrossrefPubMedGoogle Scholar
  • 28 van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988; 19 (05) 604-607
    CrossrefPubMedGoogle Scholar
  • 29 Niskanen M, Koivisto T, Ronkainen A, Rinne J, Ruokonen E. Resource use after subarachnoid hemorrhage: comparison between endovascular and surgical treatment. Neurosurgery 2004; 54 (05) 1081-1086 , discussion 1086–1088
    CrossrefPubMedGoogle Scholar